DE60229855D1 - Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben - Google Patents

Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben

Info

Publication number
DE60229855D1
DE60229855D1 DE60229855T DE60229855T DE60229855D1 DE 60229855 D1 DE60229855 D1 DE 60229855D1 DE 60229855 T DE60229855 T DE 60229855T DE 60229855 T DE60229855 T DE 60229855T DE 60229855 D1 DE60229855 D1 DE 60229855D1
Authority
DE
Germany
Prior art keywords
hydrogenicized
cinema
lipid
pharmaceutically elegant
topical ointments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60229855T
Other languages
English (en)
Inventor
David P Jones
David W Hobson
Pilar P Duque
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Healthpoint Ltd
Original Assignee
Healthpoint Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthpoint Ltd filed Critical Healthpoint Ltd
Application granted granted Critical
Publication of DE60229855D1 publication Critical patent/DE60229855D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
DE60229855T 2001-09-04 2002-07-29 Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben Expired - Lifetime DE60229855D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/945,903 US6479060B1 (en) 2001-09-04 2001-09-04 Elegant hydrogenated castor oil ointments
PCT/US2002/023954 WO2003020203A2 (en) 2001-09-04 2002-07-29 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments

Publications (1)

Publication Number Publication Date
DE60229855D1 true DE60229855D1 (de) 2008-12-24

Family

ID=25483673

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60229855T Expired - Lifetime DE60229855D1 (de) 2001-09-04 2002-07-29 Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben

Country Status (16)

Country Link
US (1) US6479060B1 (de)
EP (1) EP1423154B1 (de)
JP (1) JP4115391B2 (de)
KR (2) KR100764278B1 (de)
CN (1) CN100463697C (de)
AT (1) ATE413861T1 (de)
AU (1) AU2002330929B2 (de)
BR (1) BR0212286A (de)
CA (1) CA2459239C (de)
DE (1) DE60229855D1 (de)
DK (1) DK1423154T3 (de)
ES (1) ES2315400T3 (de)
HK (1) HK1065963A1 (de)
MX (1) MXPA04001969A (de)
PT (1) PT1423154E (de)
WO (1) WO2003020203A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US7785584B2 (en) * 2003-08-13 2010-08-31 Healthpoint, Ltd. Ointment wound spray
US20050048105A1 (en) * 2003-08-29 2005-03-03 Mcnulty Amy K. Protease inhibitor compositions for prevention and treatment of skin conditions
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
US20060264505A1 (en) * 2003-11-07 2006-11-23 Stiefel Laboratories, Inc. Dermatological compositions
US20050281806A1 (en) * 2004-06-16 2005-12-22 Collegium Pharmaceutical, Inc., Delaware Compositions for topical enzymatic debridement
US8211449B2 (en) * 2004-06-24 2012-07-03 Dpt Laboratories, Ltd. Pharmaceutically elegant, topical anhydrous aerosol foam
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
AR065378A1 (es) * 2007-02-16 2009-06-03 Procter & Gamble Articulo absorbente con locion que comprende un material de polipropilenglicol
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
KR101102857B1 (ko) * 2009-08-07 2012-01-10 남연우 주방용기
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011071986A1 (en) 2009-12-08 2011-06-16 Healthpoint, Ltd. Enzymatic wound debriding compositions with enhanced enzymatic activity
US20130053353A1 (en) * 2010-05-04 2013-02-28 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses
US9011931B1 (en) 2011-01-26 2015-04-21 Libby Robinson Wound dressing composition and method of use
WO2012112566A1 (en) * 2011-02-15 2012-08-23 Allergan, Inc. Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea
WO2012155027A1 (en) 2011-05-12 2012-11-15 Healthpoint, Ltd. Wound debridement compositions containing seaprose and methods of wound treatment using same
WO2013170128A1 (en) 2012-05-11 2013-11-14 Smith & Nephew, Inc. Use of seaprose to remove bacterial biofilm
CA3031866A1 (en) 2016-07-27 2018-02-01 Smith & Nephew, Inc. Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2018140707A1 (en) 2017-01-30 2018-08-02 Smith & Nephew, Inc. Synergistic combination of thermolysin and an antibacterial agent to reduce eliminate bacterial biofilms from surfaces
US20220395450A1 (en) * 2021-06-10 2022-12-15 Pauleine Prospere Hair Or Skin Treatment Composition And Methods Of Preparation And Use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB892450A (en) * 1959-11-18 1962-03-28 Ici Ltd Improvements in or relating to pharmaceutical compositions comprising ethylthiocarbonyl compounds
US3314972A (en) * 1965-05-21 1967-04-18 Warner Lambert Pharmaceutical Indolo[3, 2-c]thiopyrylium compounds and intermediates therefor
US5021429A (en) * 1977-05-17 1991-06-04 Allen & Hansburys Limited Pharmacologically active aminoalkylphenyl compounds and their use
JPS546002A (en) * 1977-06-17 1979-01-17 Chuo Yuka Lithium soappbase lubricating grease compositions and production thereof
DE2924005C2 (de) 1979-06-13 1984-07-05 Sanol Schwarz-Monheim Gmbh, 4019 Monheim Isosorbiddinitrat enthaltendes Mittel
NZ196700A (en) 1980-04-18 1983-04-12 Smith & Nephew Ass Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives
US4334546A (en) * 1980-09-08 1982-06-15 Kolmar Laboratories Inc. Cosmetic pencil
US5102656A (en) 1983-07-29 1992-04-07 The Mennen Company Antiperspirant creams
DE3409720A1 (de) * 1984-03-16 1985-09-19 Bayer Ag, 5090 Leverkusen Strukturviskos eingestellte silikonpasten und deren verwendung als abformmassen
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
IT1183530B (it) 1985-03-29 1987-10-22 Monteluos S P A Composizioni per cosmesi comprendente perfluoropolieteri
IT1197056B (it) * 1986-08-01 1988-11-25 Intercos Italiana Pomata per mascherare difetti della pelle e cicatrici
ATE107517T1 (de) 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
GB9405304D0 (en) 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ATE205391T1 (de) 1994-10-05 2001-09-15 Helsinn Healthcare Sa Nimesulid zur aüsserlichen anwendung
KR100192149B1 (ko) 1994-10-24 1999-06-15 이시노 요시푸사 경피 투여형 제제
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
JP4010574B2 (ja) 1994-12-05 2007-11-21 電気化学工業株式会社 皮膚外用剤
RO113156B1 (ro) * 1995-03-10 1998-04-30 Icerp Sa UNSOARE DE LITIU Șl PROCEDEU DE OBȚINERE A ACESTEIA
US6063762A (en) 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US6267970B1 (en) * 1998-03-23 2001-07-31 Avon Products, Inc. Cream cosmetic base with powdery feel
IT1302275B1 (it) * 1998-09-25 2000-09-05 Giorgio Panin Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica.
US6262117B1 (en) * 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne

Also Published As

Publication number Publication date
DK1423154T3 (da) 2009-01-26
CA2459239A1 (en) 2003-03-13
ATE413861T1 (de) 2008-11-15
AU2002330929B2 (en) 2005-06-16
BR0212286A (pt) 2006-05-23
JP2005527468A (ja) 2005-09-15
EP1423154A2 (de) 2004-06-02
KR100764278B1 (ko) 2007-10-05
HK1065963A1 (en) 2005-03-11
CA2459239C (en) 2005-06-14
CN1610563A (zh) 2005-04-27
PT1423154E (pt) 2009-01-30
CN100463697C (zh) 2009-02-25
ES2315400T3 (es) 2009-04-01
KR20040041597A (ko) 2004-05-17
JP4115391B2 (ja) 2008-07-09
KR20060086460A (ko) 2006-07-31
WO2003020203A3 (en) 2003-07-10
WO2003020203A2 (en) 2003-03-13
EP1423154B1 (de) 2008-11-12
EP1423154A4 (de) 2007-08-15
KR100638417B1 (ko) 2006-10-24
US6479060B1 (en) 2002-11-12
MXPA04001969A (es) 2004-07-08

Similar Documents

Publication Publication Date Title
DE60229855D1 (de) Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben
KR20010012902A (ko) 피부 보호 조성물 및 피부 외관의 개선 방법
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
ES2190175T3 (es) Formulacion de gel hidrofobico con base de acetato de vitamina e de aplicacion topica.
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
MY148773A (en) Galenic formulations of organic compounds
NO20052490D0 (no) Dagsdoseringsenheter for melatonin.
ATE364605T1 (de) 3-aryloxy und 3-heteroaryloxy substituierte benzo(b) thiophene als therapeutische wirkstoffe mit pi3k aktivität
HRP20100513T1 (en) Multi-phase contraceptive preparation based on a natural estrogen
RS50116B (sr) Lokalne farmaceutske kompozicije koje sadrže nimesulid
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
FR2887150B1 (fr) Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
CO4790138A1 (es) Chocolate con un contenido reducido de grasa
IL179544A0 (en) Compositions comprising flavonoids and tocotrienols and methods thereof
HK1053607A1 (en) Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
AR046226A1 (es) Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
Groenendaal–van de Meent et al. YM150, an oral direct inhibitor of factor Xa, demonstrated a predictable and dose-proportional pharmacokinetic/pharmacodynamic profile after single and multiple dosing: results from three studies
AU4142999A (en) Topical pharmaceutical compositions useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis
Ordonez et al. Administration of KER-047, a novel ALK2 Inhibitor, elicited robust and sustained increases in serum iron in healthy participants
CN106726916A (zh) 一种玫瑰精油
DE69713896D1 (de) Pharmazeutische formulierungen zur topischen verwendung mit vit. e acetate
DE602004031964D1 (de) Ndlung von dermatologischen erkrankungen
ATE340588T1 (de) Pharmazeutische zusammensetzung enthaltend träger für pharmakologisch aktive produkte wobei die träger auf vitamin e, papain und hyaluronidase basieren
AR039604A1 (es) Utilizacion de una sal de acido l-ascorbico para la preparacion de una composicion farmaceutica, para uso oftalmico topico, capaz de mejorar el nivel de acido l-ascorbico en el ojo
EA200600932A1 (ru) Таблетки циталопрама гидробромида

Legal Events

Date Code Title Description
8364 No opposition during term of opposition